Loading…
← CockpitCompetitor Analysis › JYOTHYLAB.NS Jyothy Labs LimitedOpen in the cockpit ↗

Jyothy Labs LimitedJYOTHYLAB.NSCompetitor analysis, valuation and peers

India · INR·FMCG›Household/Personal Care
Momentum weak 39
Mkt cap
$762M
US dollars, full cap
Free float
29%
of shares outstanding
$/day
$1.24M
20-day average traded
Fwd P/E
40.8×
forward earnings
ROIC−WACC
-0.6 pp
WACC 19.1%
Hurdle
+26 pp
Req g minus delivered
Next earnings
70 days
27 Jan 2027
Close · INR₹194.25
1D+0.4%
1W-1.9%
1M+2.7%
3M-7.8%
6M-9.0%
YTD-31.3%
1Y-37.4%
ATR %3.2%
Beta1.07
52w lowhigh39.1% off high

What Jyothy Labs does

Employees: 8,347

Jyothy Labs at a glance

Size Jyothy Labs (JYOTHYLAB.NS) is an India Consumer Staples company (Household/Personal Care) with a market value of $762M, the 702nd largest of 1,066 India companies the cockpit tracks. Shares closed at ₹194.25 on 18 Nov 2026.

Performance Over six months the shares fell 9.0%, against +9.2% for the median peer and +3.8% for the India market (cap-weighted) — 10th lowest of 21 in its peer set.

Growth Revenue grew 4.6% over the last twelve months (peer median +10.2%); the operating margin is 7.6% (peer median 8.8%).

Valuation It trades at 40.8× forward earnings against a peer median of 18.9× (2nd most expensive of 20).

Price implies For today's price to make sense, revenue must grow about 35% a year for seven years (Req g). Recent delivered growth is +9%, so the hurdle is +26 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 0.6 points below its cost of capital (19.1% WACC).

Next results Next results expected around 27 Jan 2027 (exchange calendar; dates can move).

Relative performance

809010011021 May 202621 Aug 202618 Nov 2026Peer median 109JYOTHYLAB.NS 93
Six months, rebased to 100: Jyothy Labs against the median of its 20 peers (local-currency closes).

Jyothy Labs financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₹29.9B₹29.4B₹28.4B₹27.7B₹25.0B
Revenue growth—+4%+3%+11%—
Gross profit₹8.18B₹9.45B₹10.00B₹9.62B₹7.02B
EBITDA₹2.91B₹4.58B₹5.06B₹4.95B₹3.31B
Net income₹2.07B₹3.33B₹3.71B₹3.69B₹2.40B
Free cash flown/a₹3.58B₹2.69B₹4.42B₹2.90B
Capital expendituren/a₹669M₹581M₹371M₹355M
Total debt₹611M₹516M₹613M₹506M₹465M

Quarterly statements and history in the cockpit →

Jyothy Labs competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%-25%0%+25%+50%-20%0%4919605009300740GALAXYSURF2417100013286031933011084928BAJAJCON2657PZC4836502145EPC003006001206603630ICOSJYOTHYLAB.NS6-month return →1-month return →
Up and to the right = strong over both horizons. Jyothy Labs is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%+80%20×40×4919605009300740GALAXYSURF2417100013286031933011084928BAJAJCON2657PZC4836502145EPC003006001206603630JYOTHYLAB.NSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Jyothy Labs is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%4919605009300740GALAXYSURF6031933011084928BAJAJCON2657PZC4836502145003006JYOTHYLAB.NSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Jyothy Labs is the large dot.

Jyothy Labs competitors and peer comparison

How Jyothy Labs compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Jyothy Labs against its 20 peers (data as of 18 Nov 2026)
MeasureJYOTHYLAB.NSPeer medianRank in peer set
1-month return+2.7%-7.9%5th highest of 21
6-month return-9.0%+9.2%10th lowest of 21
Distance from 52-week high-39.1%-33.6%9th lowest of 21
Revenue growth (TTM)+4.6%+10.2%8th lowest of 21
Operating margin7.6%8.8%9th lowest of 21
Forward P/E40.8×18.9×2nd most expensive of 20
Growth the price implies (Req g, 7 yrs)34.5%4.0%most demanding of 17
Growth delivered (Del g)+8.9%+9.5%9th highest of 17
Hurdle (Req g minus delivered)+25.6 pp-5.7 pp2nd most demanding of 17
ROIC minus cost of capital-0.6 pp+6.2 pp6th lowest of 21
EV / EBITDA22.4×10.1×most expensive of 12
Net debt / EBITDA-2.1×-0.7×2nd least indebted of 12

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Jyothy Labs JYOTHYLAB.NSIndia$762M-9%+5%8%40.8×34.5%+8.9%
Milbon 4919.TJapan$743M+48%+8%14%25.7×-3.3%+8.2%
Hangzhou Haoyue Personal Care 605009.SSChina$726M-18%+10%6%17.7×4.4%+7.7%
SYoung 300740.SZChina$816M-48%+14%3%33.4×14.0%+6.1%
Galaxy Surfactants GALAXYSURF.NSIndia$845M+22%+30%9%17.6×18.5%+13.7%
Cosmecca Korea 241710.KSSouth Korea$847M+23%+42%12%16.3×n/an/a
Dencare (Chongqing) Oral Care 001328.SZChina$912M+13%+10%11%27.9×3.7%+10.8%
Runben Biotechnology 603193.SSChina$918M-30%+13%21%18.5×1.5%+28.4%
Tongling Jieya Biologic Technology 301108.SZChina$933M+56%+24%5%52.5×28.5%+0.8%
Noevir 4928.TJapan$978M+7%-3%28%20.4×-12.8%+4.1%
Bajaj Consumer Care BAJAJCON.NSIndia$560M-24%+29%22%19.7×14.8%+5.0%
Shanghai Forest Cabin Cosmetics 2657.HKHong Kong$1.04B+15%+74%18%11.8×11.3%+49.0%
PZ Cussons PZC.LUnited Kingdom$527M+13%+5%11%12.7×-2.3%-2.1%
d'Alba Global 483650.KSSouth Korea$1.13B-55%+49%22%12.0×-6.6%+53.0%
Shanghai Chicmax Cosmetics 2145.HKHong Kong$1.17B-42%+23%8%14.4×-6.1%+21.2%
Qingdao Kingking Applied Chemistry 002094.SZChina$454M-26%+3%4%n/an/an/a
Edgewell Personal Care EPCUnited States$1.30B+67%-10%7%14.2×n/an/a
Chongqing Baiya Sanitary Products 003006.SZChina$1.35B+27%0%3%37.3×28.8%+22.8%
Tianjin Yiyi Hygiene Products 001206.SZChina$429M-15%-8%9%19.9×1.9%+6.3%
Lafang China 603630.SSChina$414M-19%+5%3%37.6×n/an/a
Intercos ICOS.MIItaly$1.43B+12%-5%9%18.9×4.3%+11.5%

Questions

Which companies are Jyothy Labs's closest peers?
The cockpit's peer set: Milbon (4919.T), Hangzhou Haoyue Personal Care (605009.SS), SYoung (300740.SZ), Galaxy Surfactants (GALAXYSURF.NS), Cosmecca Korea (241710.KS), Dencare (Chongqing) Oral Care (001328.SZ), Runben Biotechnology (603193.SS), Tongling Jieya Biologic Technology (301108.SZ).
Is Jyothy Labs expensive compared with its peers?
On forward p/e it trades at 40.8× against a peer median of 18.9×, 2nd most expensive of 20 in its peer set. For today's price to make sense, revenue must grow about 35% a year for seven years (Req g). Recent delivered growth is +9%, so the hurdle is +26 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Jyothy Labs stock performed?
Over six months to 18 Nov 2026 the shares returned -9.0% against +9.2% for the median peer; over one year -37.4%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.